The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Long Covid's Research Stalemate Made It Easy to Erase

Long Covid has not gone away. It has gone underground. That is the argument from Steven Phillips in a STAT News opinion piece, which traces how a scientific stalemate left the condition vulnerable to political erasure.

Years into the effort, researchers still lack a diagnostic test, a clear biological cause, or a proven treatment for long Covid. That ambiguity, Phillips writes, made it easy for the Trump administration and budget-cutters to step back. Without definitive findings to point to, federal funding and research attention have receded, even as millions of patients remain symptomatic and largely unseen by the health system.

The practical effect is a feedback loop. Thin evidence justifies thinner funding, which in turn slows the research that might produce answers. For health systems and payers, that means a large population of chronic patients with no standardized diagnosis or care pathway, and shrinking public investment to build one.

Sources

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.